PUNE, India, March 6, 2017 /PRNewswire/ --
According to a new market research report "Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025", published by MarketsandMarkets, the market is expected to reach USD 899.1 Million by 2025 from USD 506.5 Million in 2022 growing at a CAGR of 21.1% during the forecast period (2022-2025).
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 91 market data Tables and 30 Figures spread through 148 Pages and in-depth TOC on "Human Microbiome Market"
Early buyers will receive 10% customization on this report.
The Human Microbiome Market is segmented on the basis of application, disease, product, and region. Also, the human microbiome research spending market is broadly segmented by product and technology.
Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the Human Microbiome Market.
On the basis of disease, the Human Microbiome Market comprises of obesity, diabetes, autoimmune disorders, acute diarrhea, cancer, mental disorders, and other diseases. In 2022, the acute diarrhea segment is expected to account for the largest share and is estimated to grow at the highest CAGR during the forecast period (2022-2025).
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=37621904
On the basis of product, the human microbiome research spending market is characterized into instruments and consumables. The instruments segment is further divided into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to grow at the highest CAGR during the forecast period (2016-2021) owing to the repeated purchases of consumables as compared to instruments.
On the basis of technology, the human microbiome research spending market is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology segment is expected to account for the largest share of the global human microbiome research spending technology market in 2016. The large share can be attributed to the increasing R&D initiatives in the field of human microbiome.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=37621904
Europe is expected to account for the largest share of the global Human Microbiome Market in 2022. The large share of this region can be attributed to its significant presence in the probiotics and prebiotics fields and the acceptance of these products by its population.
A number of factors such as the rising incidence of cardiovascular disease, increasing awareness about the need for diagnostic and preventive care, and technological advancement are driving the growth of this market. In developed regions like North America, the Human Microbiome Market, in terms of value, is expected to be smaller as compared to Europe, owing to the slower acceptance of microbiome products in a number of countries in this region.
The key players in the Human Microbiome Market are Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences (U.S.), Osel (U.S.), and Merck (U.S.).
Browse Related Reports:
Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021.
Weight Loss and Weight Management Market by Equipment (Fitness Equipment (Treadmill, Stair Steppers)), Surgical Equipment (Adjustable Gastric Band, Gastric Bypass), Diet (Weight Loss Meals, Diet Soft Drinks), Weight Loss Services - Forecast to 2019.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets